You are currently viewing a new version of our website. To view the old version click .
MDPIMDPI

2 Results Found

  • Article
  • Open Access
5 Citations
3,518 Views
16 Pages
Download PDF

Potential of Anti-CMV Immunoglobulin Cytotect CP® In Vitro and Ex Vivo in a First-Trimester Placenta Model

  • Perrine Coste Mazeau,
  • Chloé Jacquet,
  • Clotilde Muller,
  • Mathis Courant,
  • Chahrazed El Hamel,
  • Thierry Chianea,
  • Sébastien Hantz and
  • Sophie Alain
Microorganisms2022, 10(4), 694;https://doi.org/10.3390/microorganisms10040694

23 March 2022

Background: Congenital CMV infection is the leading cause of neonatal neurological deficit. We herein studied in vitro and ex vivo the potential of the hyperimmune globulin Cytotect CP® (Biotest, Germany) for congenital infection prevention and t...

Full Article
  • Systematic Review
  • Open Access
16 Citations
4,711 Views
13 Pages
Download PDF

Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis

  • Markus J. Barten,
  • Fausto Baldanti,
  • Alexander Staus,
  • Christian M. Hüber,
  • Kyriaki Glynou and
  • Andreas Zuckermann
Life2022, 12(3), 361;https://doi.org/10.3390/life12030361

2 March 2022

Cytomegalovirus (CMV) is a common infection occurring in patients undergoing solid organ transplantation (SOT) or hematopoietic stem cell transplantation (HSCT). CMV-specific hyperimmunoglobulin (CMVIG) has been used for the past four decades and is...

Full Article